Form 4 Filing for Arcturus Therapeutics Holdings Inc.

Jing L. Marantz, a director at Arcturus Therapeutics Holdings Inc. (ARCT), acquired 15,000 stock options on June 5, 2026. These options, with an exercise price of $7.30, are exercisable and vest monthly over one year from the grant date. The underlying security is Common Stock. The transaction is reported on Form 4, with a signature date of June 15, 2026. This marks the annual grant for Marantz as a member of the Board of Directors.